219 related articles for article (PubMed ID: 33448631)
1. Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection.
Lachant DJ; Lachant NA; Kouides P; Rappaport S; Prasad P; White RJ
J Thromb Haemost; 2020 Oct; 18(10):2640-2645. PubMed ID: 33448631
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience.
Hanif A; Khan S; Mantri N; Hanif S; Saleh M; Alla Y; Chinta S; Shrestha N; Ji W; Attwood K; Adrish M; Jain KR
Ann Hematol; 2020 Oct; 99(10):2323-2328. PubMed ID: 32808105
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System.
Kvernland A; Kumar A; Yaghi S; Raz E; Frontera J; Lewis A; Czeisler B; Kahn DE; Zhou T; Ishida K; Torres J; Riina HA; Shapiro M; Nossek E; Nelson PK; Tanweer O; Gordon D; Jain R; Dehkharghani S; Henninger N; de Havenon A; Grory BM; Lord A; Melmed K
Neurocrit Care; 2021 Jun; 34(3):748-759. PubMed ID: 32839867
[TBL] [Abstract][Full Text] [Related]
4. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
Bikdeli B; Talasaz AH; Rashidi F; Bakhshandeh H; Rafiee F; Rezaeifar P; Baghizadeh E; Matin S; Jamalkhani S; Tahamtan O; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Khalili H; Yadollahzadeh M; Riahi T; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Amin A; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Dobesh PP; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Sadeghipour P
Thromb Haemost; 2022 Jan; 122(1):131-141. PubMed ID: 33865239
[TBL] [Abstract][Full Text] [Related]
5. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients.
Parker K; Hamilton P; Hanumapura P; Castelino L; Murphy M; Challiner R; Thachil J; Ebah L
BMC Nephrol; 2021 Jun; 22(1):224. PubMed ID: 34134645
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
Moonla C; Sosothikul D; Chiasakul T; Rojnuckarin P; Uaprasert N
Clin Appl Thromb Hemost; 2021; 27():10760296211008999. PubMed ID: 33874753
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of the safety and efficacy of enoxaparin in patients with COVID-19.
Albisinni R; Vitrone M; Ursi MP; Spiezia S; Salemme A; Florio LL; Boccia F; Iossa D; Zampino R; Atripaldi L; Squillante F; Maturo N; Fraganza F; Severino S; Punzi R; Fiorentino G
Blood Transfus; 2022 Nov; 20(6):495-504. PubMed ID: 36469432
[TBL] [Abstract][Full Text] [Related]
8. COVID-19-related thrombotic complications experience before and during delta wave.
Manzur-Pineda K; O'Neil CF; Bornak A; Lalama MJ; Shao T; Kang N; Kennel-Pierre S; Tabbara M; Velazquez OC; Rey J
J Vasc Surg; 2022 Nov; 76(5):1374-1382.e1. PubMed ID: 35700857
[TBL] [Abstract][Full Text] [Related]
9. Intracranial Hemorrhage in Hospitalized SARS-CoV-2 Patients: A Case Series.
Mousa-Ibrahim F; Berg S; Od TPDetola O; Teitcher M; Ruland S
J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105428. PubMed ID: 33161349
[TBL] [Abstract][Full Text] [Related]
10. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study.
Rentsch CT; Beckman JA; Tomlinson L; Gellad WF; Alcorn C; Kidwai-Khan F; Skanderson M; Brittain E; King JT; Ho YL; Eden S; Kundu S; Lann MF; Greevy RA; Ho PM; Heidenreich PA; Jacobson DA; Douglas IJ; Tate JP; Evans SJW; Atkins D; Justice AC; Freiberg MS
BMJ; 2021 Feb; 372():n311. PubMed ID: 33574135
[TBL] [Abstract][Full Text] [Related]
11. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
[TBL] [Abstract][Full Text] [Related]
12. Major bleeding complications in critically ill patients with COVID-19 pneumonia.
Godier A; Clausse D; Meslin S; Bazine M; Lang E; Huche F; Cholley B; Hamada SR
J Thromb Thrombolysis; 2021 Jul; 52(1):18-21. PubMed ID: 33646501
[TBL] [Abstract][Full Text] [Related]
13. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
[TBL] [Abstract][Full Text] [Related]
14. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
[TBL] [Abstract][Full Text] [Related]
15. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
16. Hemorrhagic stroke and anticoagulation in COVID-19.
Dogra S; Jain R; Cao M; Bilaloglu S; Zagzag D; Hochman S; Lewis A; Melmed K; Hochman K; Horwitz L; Galetta S; Berger J
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104984. PubMed ID: 32689588
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection.
Rubini-Costa R; Bermúdez-Jiménez F; Rivera-López R; Sola-García E; Nagib-Raya H; Moreno-Escobar E; López-Zúñiga MÁ; Briones-Través A; Sanz-Herrera F; Sequí-Sabater JM; Romero-Cabrera JL; Maíllo-Seco J; Fernández-Vázquez F; Rivadeneira-Ruiz M; López-Valero L; Gómez-Navarro C; Aparicio-Gómez JA; López MÁ; Tercedor L; Molina-Jiménez M; Macías-Ruiz R; Jiménez-Jáimez J
Med Clin (Barc); 2022 Jun; 158(12):569-575. PubMed ID: 34364707
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19.
Bemtgen X; Zotzmann V; Benk C; Rilinger J; Steiner K; Asmussen A; Bode C; Wengenmayer T; Maier S; Staudacher DL
J Thromb Thrombolysis; 2021 Feb; 51(2):301-307. PubMed ID: 32653986
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.
Antic D; Milic N; Chatzikonstantinou T; Scarfò L; Otasevic V; Rajovic N; Allsup D; Alonso Cabrero A; Andres M; Baile Gonzales M; Capasso A; Collado R; Cordoba R; Cuéllar-García C; Correa JG; De Paoli L; De Paolis MR; Del Poeta G; Dimou M; Doubek M; Efstathopoulou M; El-Ashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Lopez-Garcia A; García-Marco JA; García-Serra R; Gentile M; Gimeno E; da Silva MG; Gutwein O; Hakobyan YK; Herishanu Y; Hernández-Rivas JÁ; Herold T; Itchaki G; Jaksic O; Janssens A; Kalashnikova OB; Kalicińska E; Kater AP; Kersting S; Koren-Michowitz M; Labrador J; Lad D; Laurenti L; Fresa A; Levin MD; Mayor Bastida C; Malerba L; Marasca R; Marchetti M; Marquet J; Mihaljevic B; Milosevic I; Mirás F; Morawska M; Motta M; Munir T; Murru R; Nunes R; Olivieri J; Pavlovsky MA; Piskunova I; Popov VM; Quaglia FM; Quaresmini G; Reda G; Rigolin GM; Shrestha A; Šimkovič M; Smirnova S; Špaček M; Sportoletti P; Stanca O; Stavroyianni N; Te Raa D; Tomic K; Tonino S; Trentin L; Van Der Spek E; van Gelder M; Varettoni M; Visentin A; Vitale C; Vukovic V; Wasik-Szczepanek E; Wróbel T; Segundo LYS; Yassin M; Coscia M; Rambaldi A; Montserrat E; Foà R; Cuneo A; Carrier M; Ghia P; Stamatopoulos K
J Hematol Oncol; 2022 Aug; 15(1):116. PubMed ID: 36028857
[TBL] [Abstract][Full Text] [Related]
20. Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia.
Tacquard C; Mansour A; Godon A; Godet J; Poissy J; Garrigue D; Kipnis E; Rym Hamada S; Mertes PM; Steib A; Ulliel-Roche M; Bouhemad B; Nguyen M; Reizine F; Gouin-Thibault I; Besse MC; Collercandy N; Mankikian S; Levy JH; Gruel Y; Albaladejo P; Susen S; Godier A;
Chest; 2021 Jun; 159(6):2417-2427. PubMed ID: 33465342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
